Anika Therapeutics, Inc. (ANIK) vs Lexeo Therapeutics, Inc. Common Stock (LXEO)

A side-by-side comparison of Anika Therapeutics, Inc. and Lexeo Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Anika Therapeutics, Inc. logo
ANIK
Anika Therapeutics, Inc.
$256M
$19.16HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Lexeo Therapeutics, Inc. Common Stock logo
LXEO
Lexeo Therapeutics, Inc. Common Stock
$253M
$3.22HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

Total return — ANIK vs LXEO

growth of $100 · dividends reinvested · last 3y
ANIK +5.2% (+1.7%/yr)LXEO -66.1% (-30.3%/yr)ANIK compounded faster over this window
50100150200Start $100202420252026$105$34
ANIK LXEO

ANIK vs LXEO: by the numbers

  • •ANIK is the larger company ($256M vs $253M market cap).
  • •Both run net losses; LXEO's is the smaller (0.00% vs -3.14% net margin).

Metrics side by side

Valuation

MetricANIKLXEO
Forward P/E18.24N/A
P/S ratio2.12N/A
P/B ratio1.871.08
EV / EBITDA473.98N/A
FCF yield0.22%N/A

Profitability

MetricANIKLXEO
Gross margin62.16%0.00%
Operating margin-4.24%0.00%
Net margin-3.14%0.00%
ROE-2.76%-37.12%
ROIC-3.17%-39.76%

Growth (annualized)

MetricANIKLXEO
Revenue CAGR (5Y)-2.48%N/A
FCF CAGR (5Y)-39.38%N/A
Total return CAGR (5Y)-13.40%N/A

Go deeper

Full ANIK analysisFull LXEO analysisInteractive comparison tool

Dig into the metrics

Anika Therapeutics ROELexeo Therapeutics, Inc. Common Stock ROEAnika Therapeutics operating marginLexeo Therapeutics, Inc. Common Stock operating marginAnika Therapeutics revenue growthLexeo Therapeutics, Inc. Common Stock revenue growthAnika Therapeutics free cash flowLexeo Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.